Furthermore, these findings support previous studies using animal models regarding the neuroprotective and anti-inflammatory properties of MY10, validating the PTN/MK–RPTPβ/ζ signaling axis as a promising therapeutic target in ethanol-induced brain injury (Calleja-Conde et al., 2020; Fernández-Calle et al., 2018; Fernández-Calle et al., 2019; Fernández-Calle et al., 2020; Galán-Llario et al., 2023a; Galán-Llario et al., 2023b; Herradon et al., 2019). The gene discussed is PTPRZ1; the disease is brain injury.